Serum ALT levels are a marker of liver cell injury [29], as well as NAFLD, hepatocellular carcinoma, type 2 diabetes, and cardiovascular disease [30]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.